Editorial: Postoperative management of Crohn's disease: One size does not fit all
The corresponding author confirms on behalf of all authors that there have been no involvements that might raise the question of bias in the work reported or in the conclusions, implications, or opinions stated. Eugeni Domènech has served as a speaker or has received research or educational funding or advisory fees from AbbVie, Adacyte Therapeutics, Biogen, Celltrion, Galapagos, Gilead, Janssen, Kern Pharma, MSD, Pfizer, Roche, Samsung, Takeda, Tillots; Míriam Mañosa has served as a speaker and has received research or educational funding from MSD, AbbVie, Takeda, Janssen, Faes Farma, Ferring and Pfizer; Margalida Calafat has served as a speaker for Takeda, Janssen, Faes Farma, and MSD. 

